Skip to main content
. 2013 Jun 17;6:83–90. doi: 10.2147/JIR.S43081

Table 2.

Revascularization and drug therapy during follow-up

Therapy, n (%) Patients with MI without type 2 diabetes (n = 95) Patients with MI and type 2 diabetes (n = 60)
β-blockers 85 (89.5) 51 (85)
Angiotensin-converting enzyme 78 (82.1) 51 (85)
Calcium channel blocker 66 (69.5) 39 (65)
Diuretics 40 (42) 39 (60)
Nitrates 83 (87.4) 31 (51.6)
Aspirin 94 (87.8) 55 (91.6)
Heparin 95 (100) 60 (100)
Clopidogrel 84 (78.5) 44 (73.3)
Statins 95 (100) 60 (100)

Abbreviation: MI, myocardial infarction.

HHS Vulnerability Disclosure